UMIN-CTR Clinical Trial

Basic information
Public title	The influence of difference of joint angle on posture of stance on systemic reaction time
Acronym	The influence of difference of joint angle on posture of stance on systemic reaction time
Scientific Title	The influence of difference of joint angle on posture of stance on systemic reaction time
Scientific Title:Acronym	The influence of difference of joint angle on posture of stance on systemic reaction time
Region	Japan

Condition
Condition	Healthy adult person
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	By verifying the relationship between the angle of the spinal column in the stance posture, the pelvic angle of inclination, the angle of the lower limb joint angle and the reaction time of the whole body, it is clarified which factor has the most effect on the whole body reaction time, and guidance at the sports scene for the purpose of helping.
Basic objectives2	Bio-equivalence
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Lumbar lordosis angle
Key secondary outcomes

Base
Study type	Interventional

Study design
Basic design	Single arm
Randomization	Non-randomized
Randomization unit
Blinding	Open -no one is blinded
Control	Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	1
Purpose of intervention	Educational,Counseling,Training
Type of intervention	Behavior,custom
Interventions/Control_1	Measurement of whole body reaction time, lower limb joint angle, spinal angle
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	24 years-old >=
Gender	Male
Key inclusion criteria	Person who belongs to Hiroshima University and obtains consent of this research
Key exclusion criteria	Persons who hava orthopedic disease history or merger
Target sample size	20

Research contact person
Name of lead principal investigator	1st name Yukio Middle name Last name Urabe
Organization	Graduate School of Biomedical & Health Sciences, Hiroshima University
Division name	Graduate School of Biomedical & Health Sciences, Hiroshima University
Zip code	734-8551
Address	Hiroshima Prefecture Hiroshima-shi Minami-ku 1-2-3 Kasumi
TEL	082-257-5405
Email	yurabe@hirosima-u.ac.jp

Public contact
Name of contact person	1st name Kazuki Middle name Last name Fukui
Organization	Graduate School of Biomedical & Health Sciences, Hiroshima University
Division name	Graduate School of Biomedical & Health Sciences, Hiroshima University
Zip code	734-8551
Address	Hiroshima Prefecture Hiroshima-shi, Minami-ku, Tomei 3 - chome 10 - 6
TEL	090-4783-2814
Homepage URL
Email	b133727@gmail.com

Sponsor
Institute	Graduate School of Biomedical & Health Sciences, Hiroshima University
Institute
Department

Funding Source
Organization	NONE
Organization
Division
Category of Funding Organization	Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Ethical Committee for Clinical Research of Hiroshima University
Address	Kasumi 1-2-3 Minami-ku, Hiroshima 734-8551
Tel	082-257-1551
Email	iryo-seisaku@office.hir

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2017 Year 02 Month 01 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled	30
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2017 Year 03 Month 01 Day
Date of IRB	2017 Year 01 Month 17 Day
Anticipated trial start date	2017 Year 04 Month 01 Day
Last follow-up date	2019 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2017 Year 02 Month 01 Day
Last modified on	2019 Year 10 Month 10 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029838